Lyka Labs Ltd vs Quest Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Lyka Labs Ltd is ₹ 58.72 as of 05 May 15:30 . The P/E Ratio of Lyka Labs Ltd changed from 10 on March 2022 to 45.1 on March 2025 . This represents a CAGR of 45.73% over 4 yearsThe P/E Ratio of Quest Laboratories Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Lyka Labs Ltd changed from ₹ 74.59 crore on March 2021 to ₹ 360.29 crore on March 2025 . This represents a CAGR of 37.02% over 5 yearsThe Market Cap of Quest Laboratories Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Lyka Labs Ltd for the Dec '25 is ₹ 31.89 crore as compare to the Sep '25 revenue of ₹ 37.75 crore. This represent the decline of -15.52% The revenue of Quest Laboratories Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Lyka Labs Ltd for the Dec '25 is ₹ 2.81 crore as compare to the Sep '25 ebitda of ₹ -1.45 crore. This represent the decline of -293% The ebitda of Quest Laboratories Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Lyka Labs Ltd changed from ₹ 1.29 crore to ₹ -0.15 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Quest Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Lyka Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Quest Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Lyka Labs Ltd

Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83.
It also added a range of ayurvedic and animal health care products over the years.
In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan.
Lyka Exports is the subsidiary of the company.
The Company is engaged in the development, manufacture and marketing of quality finished dosages. The company offers a broad range of antibiotics used as life-savers and to treat minor infections.

About Quest Laboratories Ltd

Quest Laboratories Limited was originally incorporated as 'Quest Laboratories Private Limited' vide Certificate of Incorporation dated June 01, 1998, with the Registrar of Companies, Gwalior.
Thereafter, the status of the Company changed to Public Limited and the name of Company was changed to 'Quest Laboratories Limited' vide fresh Certificate of Incorporation issued on January 23, 2024, by Centralised Processing Centre. The Company is engaged in manufacturing of pharmaceutical formulations including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more.
It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC).
The Company is an ISO 9001:2015 in accordance with the requirements Quality Management System standard.

FAQs for the comparison of Lyka Labs Ltd and Quest Laboratories Ltd

Which company has a larger market capitalization, Lyka Labs Ltd or Quest Laboratories Ltd?

Market cap of Lyka Labs Ltd is 220 Cr while Market cap of Quest Laboratories Ltd is 236 Cr

What are the key factors driving the stock performance of Lyka Labs Ltd and Quest Laboratories Ltd?

The stock performance of Lyka Labs Ltd and Quest Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lyka Labs Ltd and Quest Laboratories Ltd?

As of May 5, 2026, the Lyka Labs Ltd stock price is INR ₹61.74. On the other hand, Quest Laboratories Ltd stock price is INR ₹144.1.

How do dividend payouts of Lyka Labs Ltd and Quest Laboratories Ltd compare?

To compare the dividend payouts of Lyka Labs Ltd and Quest Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.